| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alphavirus RNA helper cells; Venezuelan-horse-encephalitis virus, Sindbis virus, Semliki-Forest virus attenuation and recombinant vaccine particle production in packaging cell culture
|
|
|
1997
|
15 |
4 |
p. 461-
1 p.
|
article
|
| 2 |
Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule—results of a post-marketing surveillance
|
Clemens, Ralf
|
|
1997
|
15 |
4 |
p. 349-352
4 p.
|
article
|
| 3 |
Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule®): comparison with standard syringe injection
|
du Châtelet, Isabelle Parent
|
|
1997
|
15 |
4 |
p. 449-458
10 p.
|
article
|
| 4 |
Detecting and preventing Trypanosoma cruzi infection; expression of a T. cruzi antigen and application as a recombinant vaccine or in an immunoassay for infection detection
|
|
|
1997
|
15 |
4 |
p. 461-
1 p.
|
article
|
| 5 |
DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice
|
He, Junkun
|
|
1997
|
15 |
4 |
p. 357-362
6 p.
|
article
|
| 6 |
Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity
|
Baldridge, Jory R.
|
|
1997
|
15 |
4 |
p. 395-401
7 p.
|
article
|
| 7 |
Hepatitis B vaccine administration: comparison between jet-gun and syringe and needle
|
Matheï, Catharina
|
|
1997
|
15 |
4 |
p. 402-404
3 p.
|
article
|
| 8 |
Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a Murine tumor model
|
Carroll, Miles W.
|
|
1997
|
15 |
4 |
p. 387-394
8 p.
|
article
|
| 9 |
Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin
|
Yang, Chunfu
|
|
1997
|
15 |
4 |
p. 377-386
10 p.
|
article
|
| 10 |
Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines
|
Ikonomidis, Georgios
|
|
1997
|
15 |
4 |
p. 433-440
8 p.
|
article
|
| 11 |
Large-scale production in Pichia pastoris of the recombinant vaccine Gavac™ against cattle tick
|
Canales, Mario
|
|
1997
|
15 |
4 |
p. 414-422
9 p.
|
article
|
| 12 |
Long-term persistence of anti-HAV antibodies following active immunization with hepatitis A vaccine
|
Maiwald, H.
|
|
1997
|
15 |
4 |
p. 346-348
3 p.
|
article
|
| 13 |
New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus
|
Wood, D.J.
|
|
1997
|
15 |
4 |
p. 341-345
5 p.
|
article
|
| 14 |
New human cytomegalo virus peptides; peptide production for recombinant vaccine generation and virus infection diagnosis
|
|
|
1997
|
15 |
4 |
p. 461-
1 p.
|
article
|
| 15 |
Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection
|
Weltzin, Richard
|
|
1997
|
15 |
4 |
p. 370-376
7 p.
|
article
|
| 16 |
Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T Helper Epitopes (PADRE) for antibody responses in vivo
|
del Guercio, Marie-France
|
|
1997
|
15 |
4 |
p. 441-448
8 p.
|
article
|
| 17 |
Preparation of diphtheria vaccines using highly purified toxins
|
Relyveld, Edgar
|
|
1997
|
15 |
4 |
p. 459-460
2 p.
|
article
|
| 18 |
Randomized, comparative trial of 20 μg vs 40 μg Engerix B vaccine in hepatitis B vaccine non-responders
|
Goldwater, Paul N.
|
|
1997
|
15 |
4 |
p. 353-356
4 p.
|
article
|
| 19 |
Romurtide, a synthetic muramyl dipeptide derivative, promotes megakaryocytopoiesis through stimulation of cytokine production in nonhuman primates with myelosuppression
|
Namba, Kenji
|
|
1997
|
15 |
4 |
p. 405-413
9 p.
|
article
|
| 20 |
Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174–187 from the G glycoprotein: the role of cysteinyl residues in protection
|
Simard, Claire
|
|
1997
|
15 |
4 |
p. 423-432
10 p.
|
article
|
| 21 |
Vaccine against flavivirus infection containing recombinant envelope protein; vector expression in Saccharomyces cerevisiae and monclonal antibody for e.g. dengue virus, Japanese-encephalitis virus and yellow-fever virus infection therapy
|
|
|
1997
|
15 |
4 |
p. 461-
1 p.
|
article
|
| 22 |
Vaccine against human tumor; comprises a B-lymphocyte immortalized using Epstein-Barr virus and expressing the human mucin gene after plasmid pRep4MUC1 transfection
|
|
|
1997
|
15 |
4 |
p. 461-
1 p.
|
article
|
| 23 |
Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice
|
Hart, Mary Kate
|
|
1997
|
15 |
4 |
p. 363-369
7 p.
|
article
|
Journal description